Article Details
Retrieved on: 2025-01-27 13:41:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti- CD137 IgG4 monoclonal ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here